| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b44b545635c0ac8550ce45ad3923f1fe |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D265-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-538
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D265-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-538
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate |
2000-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a27b95f4d475499a008fb2a219f9417
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f04425bac7e756c6c2046f0e05683e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f63880bfb19fa94f93ddf2e8ecc67f83
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a707d38b64695e62a394a895c0ddecd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95ba3e02417411b827ce8f8f9a8e9cb7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f9fcc32cd15c8bf22f542c97bfc8bdd |
| publicationDate |
2000-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2370401-A1 |
| titleOfInvention |
Novel polymorphic forms of an antidiabetic agent: process for their preparation and pharmaceutical compositions containing them |
| abstract |
This invention relates to novel polymorphic/pseudopolymorphic forms of arginine salt of 3-[4-[2-(phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxypropanoic acid, having formula (I). The invention also relates to a pharmaceutical composition comprising the novel polymorphic form or their mixture and a pharmaceutically acceptable carrier. The polymorphic forms of the present invention are more active, as antidiabetic and hypolipidemic agent, than the novel 3-[4-[2-(phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxypropanoic acid.</SDOA B> |
| priorityDate |
1999-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |